These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 10641699)

  • 21. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
    Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
    J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of childhood spasticity secondary to cerebral palsy using Botox.
    Gill C; Covington C; Padaliya B; Newman W; Pomeroy T; Charles PD
    Tenn Med; 2003 Nov; 96(11):511-3. PubMed ID: 14635360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
    Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
    Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.
    Delgado MR; Tilton A; Russman B; Benavides O; Bonikowski M; Carranza J; Dabrowski E; Dursun N; Gormley M; Jozwiak M; Matthews D; Maciag-Tymecka I; Unlu E; Pham E; Tse A; Picaut P
    Pediatrics; 2016 Feb; 137(2):e20152830. PubMed ID: 26812925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum A toxins in the treatment of spasticity in cerebral palsy during childhood].
    García Ruiz PJ; Sánchez Bernardos V; Urcelay V; San Martín V; Castillo F; Ferrer A; Campos J; García de Yébeñes J
    Neurologia; 1996 Jan; 11(1):34-6. PubMed ID: 8714175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated feature assessment in instrumented gait analysis.
    Wolf S; Loose T; Schablowski M; Döderlein L; Rupp R; Gerner HJ; Bretthauer G; Mikut R
    Gait Posture; 2006 Apr; 23(3):331-8. PubMed ID: 15955701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M; O'Flaherty SJ; Waugh MC
    Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
    Yap R; Majnemer A; Benaroch T; Cantin MA
    Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
    Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
    J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
    J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N; Dursun E; Alican D
    Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.